Mangham CM[au] - Search Results

Year	Number of Results
1986	1
1990	1
1993	2
1994	1
1995	1
1996	1
1998	1
1999	1
2000	1
2002	1
2010	1
2011	1
2012	1
2022	0

1

Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.

Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Scholefield JH, et al. Among authors: mangham cm. Gut. 2012 Jul;61(7):1036-40. doi: 10.1136/gutjnl-2011-300774. Epub 2011 Nov 3. Gut. 2012. PMID: 22052062

2

Screening for colorectal cancer reduces emergency admissions.

Scholefield JH, Robinson MH, Mangham CM, Hardcastle JD. Scholefield JH, et al. Among authors: mangham cm. Eur J Surg Oncol. 1998 Feb;24(1):47-50. doi: 10.1016/s0748-7983(98)80125-x. Eur J Surg Oncol. 1998. PMID: 9542516

3

Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.

Whynes DK, Mangham CM, Balfour TW, Scholefield JH. Whynes DK, et al. Among authors: mangham cm. Gut. 2010 Aug;59(8):1088-93. doi: 10.1136/gut.2009.192971. Gut. 2010. PMID: 20639252 Clinical Trial.

4

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Hardcastle JD, et al. Among authors: mangham cm. Lancet. 1996 Nov 30;348(9040):1472-7. doi: 10.1016/S0140-6736(96)03386-7. Lancet. 1996. PMID: 8942775 Clinical Trial.

5

Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.

Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Scholefield JH, et al. Among authors: mangham cm. Gut. 2002 Jun;50(6):840-4. doi: 10.1136/gut.50.6.840. Gut. 2002. PMID: 12010887 Free PMC article. Clinical Trial.

6

The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, Scholefield JH, Mangham CM. Robinson MH, et al. Among authors: mangham cm. Gut. 1999 Oct;45(4):588-92. doi: 10.1136/gut.45.4.588. Gut. 1999. PMID: 10486370 Free PMC article. Clinical Trial.

7

Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.

Thomas WM, Pye G, Hardcastle JD, Mangham CM. Thomas WM, et al. Among authors: mangham cm. Br J Surg. 1990 Mar;77(3):277-9. doi: 10.1002/bjs.1800770313. Br J Surg. 1990. PMID: 2322789 Clinical Trial.

8

Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer.

Robinson MH, Moss SM, Hardcastle JD, Whynes DK, Chamberlain JO, Mangham CM. Robinson MH, et al. Among authors: mangham cm. J Med Screen. 1995;2(1):41-4. doi: 10.1177/096914139500200111. J Med Screen. 1995. PMID: 7497145 Clinical Trial.

9

Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.

Robinson MH, Rodrigues VC, Hardcastle JD, Chamberlain JO, Mangham CM, Moss SM. Robinson MH, et al. Among authors: mangham cm. J Med Screen. 2000;7(2):97-8. doi: 10.1136/jms.7.2.97. J Med Screen. 2000. PMID: 11002450

10

Faecal occult blood screening of first degree relatives of patients with colorectal cancer.

Armitage NC, Farrands PA, Mangham CM, Hardcastle JD. Armitage NC, et al. Among authors: mangham cm. Int J Colorectal Dis. 1986 Oct;1(4):248-50. doi: 10.1007/BF01648347. Int J Colorectal Dis. 1986. PMID: 3598320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results